Home | Arts - Entertainment | Television
Hythiam, Inc. (NASDAQ:HYTM) announced today that the Company, and the PROMETA Treatment Program, were featured on CBS Television’s 60 Minutes on Sunday, December 9th at 7:00 p.m. PST. The full episode, titled “Prescription For Addiction,” and an accompanying feature article are available on the CBS News website: http://tinyurl.com/37sgup. Among the highlights from the episode were interviews with private and criminal justice patients successfully treated in Pierce County, Washington by Hythiam licensee Pierce County Alliance. Both patients attributed their complete absence of methamphetamine cravings directly to the impact of the PROMETA Treatment Program. Pierce County has allocated $575,000 in their 2008 budget to ‘break the cycle of addiction,’ which programs such as PROMETA are eligible for. According to PROMETA Treated patient Matt Wild, “I just don't got no cravings. I mean, it's personally, for me, it's a wonder.” The main patient featured on the episode, an addict of 20 years named David Smart, discussed the ravages of his personal struggles with addiction with CBS correspondent Scott Pelley. "I tried NA. I tried AA. I tried in-patient treatment centers. I tried outpatient treatment centers. I've been to jail and to prison many times for different crimes due to meth,” he told the reporter. After his treatment with the PROMETA Treatment Program, Smart confessed that his “cravings were gone overnight.” Also discussed on the show was the recent validation for the PROMETA Treatment Program from top-line release of data from a double-blind controlled study of PROMETA conducted by Harold Urschel, III, M.D., M.M.A. The 30-day study demonstrated that the PROMETA Treatment Program significantly reduced cravings for methamphetamine. About the PROMETA® Treatment Program Hythiam's PROMETA® Treatment Program is designed for use by healthcare providers seeking to treat individuals diagnosed with dependencies to alcohol, cocaine or methamphetamine, as well as combinations of these drugs. The PROMETA® Treatment Program includes nutritional supplements, FDA-approved oral and IV medications used off-label and separately administered in a unique dosing algorithm, as well as psychosocial or other recovery-oriented therapy chosen by the patient and his or her treatment provider. As a result, PROMETA® represents an innovative approach to managing alcohol, cocaine, or methamphetamine dependence that is designed to address physiological, nutritional, and psychosocial aspects of the disease, and is thereby intended to offer patients an opportunity to achieve sustained recovery. To learn more, please visit www.prometainfo.com. About Hythiam, Inc. Hythiam, Inc. provides behavioral health management services to health plans, employers, criminal justice, and government agencies through a network of licensed and company managed providers. The company approaches the management of behavioral health disorders with a focus on using the latest medical and health technology towards improved outcomes and out-patient treatment. Hythiam also researches, develops, licenses and commercializes innovative and proprietary physiological, nutritional, and behavioral treatment programs. Hythiam offers disease management for substance dependence built around its proprietary PROMETA® Treatment Program for alcoholism and dependence to stimulants. The PROMETA® Treatment Program, which integrates behavioral, nutritional, and medical components, is available through both licensed treatment providers and company managed PROMETA® Centers. Hythiam does not practice medicine or manufacture, distribute, or sell any medications and has no relationship with any manufacturers or distributors of medications used in the PROMETA® Treatment Program
Article Source: http://www.share.onlypunjab.com
For more information visit www.hythiam.com.
Please Rate this Article
5 out of 54 out of 53 out of 52 out of 51 out of 5
# of Ratings = 1 | Rating = 1/5
